Founded in 2014 and headquartered in Bridgewater, New Jersey, Asana BioSciences, LLC is a research and development company specializing in the discovery and development of new chemical and biological entities. Led by Dr. Sandeep Gupta, Asana’s portfolio consists of multiple early-stage drug discovery and development candidates in a variety of therapeutic areas, including oncology, pain and inflammation, among others.  

In May 2014, Tarsadia’s investor group led Asana’s acquisition of its portfolio of new chemical and biological entities from Endo Pharmaceuticals, a subsidiary of Endo International plc.  Subsequent to the acquisition, Tarsadia’s investor group remains Asana’s lead financial partner and provides capital to Asana to enable its discovery, pre-clinical and clinical initiatives and studies.